Phototherapy of psoriasis in the era of biologics: still in

Type:Uv phototherapy   Time:2014-12-08 11:58:18
Phototherapy of psoriasis in the era of biologics: still in.
Ben¨¢kov¨¢ N.
Author information
Abstract
This article reviews recent literature on phototherapy for psoriasis, particularly narrowband UVB. The efficacy, safety, 

tolerability and acceptance of phototherapy are discussed. It focuses in detail on how to improve the efficacy and safety in 

practice by trying to optimize the protocols, using combination therapy, monitoring the cumulative dose and providing skin 

cancer surveillance. Careful patient selection, individualized treatment, long-term therapy plan and complex approach to 

patients are the prerequisites for this. Narrowband UVB as the most widely used modality of phototherapy for psoriasis has a 

relatively good efficacy, cost, availability and minimal side effects. It represents a valuable treatment, which deserves 

more utilization and research. Although not so dynamic as in systemic drugs, research into phototherapy is ongoing. Even in 

the era of biologics, phototherapy remains an important therapeutic modality for psoriasis and other dermatoses and 

represents an essential part of modern dermatological therapy.
www.kerneluvb.com----The leader manufacturer of UV Phototherapy.